Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Beta2-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men

Research output: Contribution to journalJournal articleResearchpeer-review

  1. High bone mineral density in lifelong trained female team handball players and young elite football players

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The physiology of rowing with perspective on training and health

    Research output: Contribution to journalReviewResearchpeer-review

  3. Ultrasound speckle tracking of Achilles tendon in individuals with unilateral tendinopathy: a pilot study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Investigating circadian clock gene expression in human tendon biopsies from acute exercise and immobilization studies

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Airway hyperresponsiveness to inhaled mannitol identifies a cluster of non-eosinophilic asthma patients with high symptom burden

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Unique Aspects of Asthma in Women

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long-term neurotoxicity and quality of life in testicular cancer survivors-a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Hormone Replacement Therapy and Development of New Asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE: β2-Agonists have been proposed as weight-loss treatment, because they elevate energy expenditure. However, it is unknown what effect β2-agonists have on energy expenditure in overweight individuals. Furthermore, the influence of β2-agonist R- and S-enantiomer ratio for the increased energy expenditure is insufficiently explored.

METHODS: Nineteen males were included in the study of which 14 completed. Subjects were 31.6 (±3.5) years [mean (±95% CI)] and had a fat percentage of 22.7 (±2.1)%. On separate days, subjects received either placebo or inhaled racemic (rac-) formoterol (2 × 27 µg). After an overnight fast, energy expenditure and substrate oxidation were estimated by indirect calorimetry at rest and during submaximal exercise. Plasma (R,R)- and (S,S)-formoterol enantiomer levels were measured by ultra-performance liquid chromatograph-mass spectrometry.

RESULTS: At rest, energy expenditure and fat oxidation were 12% (P ≤ 0.001) and 38% (P = 0.006) higher for rac-formoterol than placebo. Systemic (R,R):(S,S) formoterol ratio was correlated with change in energy expenditure at rest in response to rac-formoterol (r = 0.63, P = 0.028), whereas no association was observed between fat percentage and rac-formoterol-induced change in energy expenditure. During exercise, energy expenditure was not different between treatments, although carbohydrate oxidation was 15% higher (P = 0.021) for rac-formoterol than placebo. Rac-formoterol-induced shift in substrate choice from rest to exercise was related to plasma ln-rac-formoterol concentrations (r = 0.75, P = 0.005).

CONCLUSION: Selective β2-adrenoceptor agonism effectively increases metabolic rate and fat oxidation in overweight individuals. The potential for weight loss induced by β2-agonists may be greater for R-enantiopure formulations.

Original languageEnglish
JournalEuropean Journal of Applied Physiology and Occupational Physiology
Volume117
Issue number9
Pages (from-to)1907–1915
ISSN1439-6319
DOIs
Publication statusPublished - Sep 2017

    Research areas

  • Journal Article

ID: 51980439